CytomX Q4 2022 Earnings Preview

Mar. 26, 2023 5:35 PM ETCytomX Therapeutics, Inc. (CTMX)By: Deepa Sarvaiya, SA News Editor
  • CytomX (NASDAQ:CTMX) is scheduled to announce Q4 earnings results on Monday, March 27th, after market close.
  • The consensus EPS Estimate is -$0.24 (+81.5% Y/Y) and the consensus Revenue Estimate is $18.37M (-73.6% Y/Y).
  • Over the last 1 year, CTMX has beaten EPS estimates 25% of the time and has beaten revenue estimates 25% of the time.
  • Over the last 3 months, EPS estimates have seen 0 upward revisions and 0 downward. Revenue estimates have seen 0 upward revisions and 1 downward.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.